124 related articles for article (PubMed ID: 38655619)
1. DPP3 promotes breast cancer tumorigenesis by stabilizing FASN and promoting lipid synthesis.
Fu X; Li X; Wang W; Li J
Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):805-818. PubMed ID: 38655619
[TBL] [Abstract][Full Text] [Related]
2. DPP3 expression promotes cell proliferation and migration
Liu JK; Abudula A; Yang HT; Xu LX; Nuerrula Y; Bai G; Tulahong A; Eli M
Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36382663
[TBL] [Abstract][Full Text] [Related]
3. DPP3/CDK1 contributes to the progression of colorectal cancer through regulating cell proliferation, cell apoptosis, and cell migration.
Tong Y; Huang Y; Zhang Y; Zeng X; Yan M; Xia Z; Lai D
Cell Death Dis; 2021 May; 12(6):529. PubMed ID: 34023852
[TBL] [Abstract][Full Text] [Related]
4. Involvement of DPP3 in modulating oncological features and oxidative stress response in esophageal squamous cell carcinoma.
Arora M; Kumari S; Kadian L; Anupa G; Singh J; Kumar A; Verma D; Pramanik R; Kumar S; Yadav R; Chopra A; Chauhan SS
Biosci Rep; 2023 Sep; 43(9):. PubMed ID: 37531267
[TBL] [Abstract][Full Text] [Related]
5. NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress-Induced DPP3-KEAP1 Interaction.
Lu K; Alcivar AL; Ma J; Foo TK; Zywea S; Mahdi A; Huo Y; Kensler TW; Gatza ML; Xia B
Cancer Res; 2017 Jun; 77(11):2881-2892. PubMed ID: 28416489
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase 3 modulates the renin-angiotensin system in mice.
Jha S; Taschler U; Domenig O; Poglitsch M; Bourgeois B; Pollheimer M; Pusch LM; Malovan G; Frank S; Madl T; Gruber K; Zimmermann R; Macheroux P
J Biol Chem; 2020 Oct; 295(40):13711-13723. PubMed ID: 32546481
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl-peptidase 9 regulates the dynamics of tumorigenesis and metastasis in breast cancer.
Heß L; Aliar K; Grünwald BT; Griffin R; Lozan A; Knöller M; Khokha R; Brummer T; Reinheckel T
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167133. PubMed ID: 38531482
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1.
Singh R; Yadav V; Kumar S; Saini N
Sci Rep; 2015 Dec; 5():17454. PubMed ID: 26632252
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl-peptidase 3 protects oxygen-glucose deprivation/reoxygenation-injured hippocampal neurons by suppressing apoptosis, oxidative stress and inflammation via modulation of Keap1/Nrf2 signaling.
Ren X; Yu J; Guo L; Ma H
Int Immunopharmacol; 2021 Jul; 96():107595. PubMed ID: 33812256
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers.
Aiderus A; Black MA; Dunbier AK
BMC Cancer; 2018 Aug; 18(1):805. PubMed ID: 30092766
[TBL] [Abstract][Full Text] [Related]
11. Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer.
Du T; Sikora MJ; Levine KM; Tasdemir N; Riggins RB; Wendell SG; Van Houten B; Oesterreich S
Breast Cancer Res; 2018 Sep; 20(1):106. PubMed ID: 30180878
[TBL] [Abstract][Full Text] [Related]
12. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
Huang LH; Chung HY; Su HM
BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid synthase is a primary target of MiR-15a and MiR-16-1 in breast cancer.
Wang J; Zhang X; Shi J; Cao P; Wan M; Zhang Q; Wang Y; Kridel SJ; Liu W; Xu J; Zhang Q; Sui G
Oncotarget; 2016 Nov; 7(48):78566-78576. PubMed ID: 27713175
[TBL] [Abstract][Full Text] [Related]
14. NDRG1 regulates neutral lipid metabolism in breast cancer cells.
Sevinsky CJ; Khan F; Kokabee L; Darehshouri A; Maddipati KR; Conklin DS
Breast Cancer Res; 2018 Jun; 20(1):55. PubMed ID: 29898756
[TBL] [Abstract][Full Text] [Related]
15. Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer.
Jung YY; Kim HM; Koo JS
PLoS One; 2015; 10(9):e0137204. PubMed ID: 26334757
[TBL] [Abstract][Full Text] [Related]
16. Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.
Corominas-Faja B; Vellon L; Cuyàs E; Buxó M; Martin-Castillo B; Serra D; García J; Lupu R; Menendez JA
Histol Histopathol; 2017 Jul; 32(7):687-698. PubMed ID: 27714708
[TBL] [Abstract][Full Text] [Related]
17. Leucine deprivation inhibits proliferation and induces apoptosis of human breast cancer cells via fatty acid synthase.
Xiao F; Wang C; Yin H; Yu J; Chen S; Fang J; Guo F
Oncotarget; 2016 Sep; 7(39):63679-63689. PubMed ID: 27579768
[TBL] [Abstract][Full Text] [Related]
18. FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β-catenin pathway.
Lu F; Ye M; Hu C; Chen J; Yan L; Gu D; Xu L; Tian Y; Bai J; Tang Q
Cancer Sci; 2023 Sep; 114(9):3553-3567. PubMed ID: 37302809
[TBL] [Abstract][Full Text] [Related]
19. FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma.
Chianese U; Papulino C; Ali A; Ciardiello F; Cappabianca S; Altucci L; Carafa V; Benedetti R
J Transl Med; 2023 Jan; 21(1):32. PubMed ID: 36650542
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression.
He Y; Xu S; Qi Y; Tian J; Xu F
J Ovarian Res; 2021 Nov; 14(1):163. PubMed ID: 34789312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
